Surgical excision margins in primary cutaneous melanoma: A meta-analysis and Bayesian probability evaluation

Cancer Treatment Reviews

Volumn 42, Issue , 2016, Pages 73-81

  Wheatley, Keith ^a   Wilson, Jayne S ^a   Gaunt, Piers ^a   Marsden, Jerry R ^b  

^a IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

^b QUEEN ELIZABETH HOSPITAL   (United Kingdom)

Author keywords

Bayesian; Margin; Melanoma; Meta analysis; Survival; Systematic review

Indexed keywords

BAYES THEOREM; CANCER PROGNOSIS; CANCER SPECIFIC SURVIVAL; CUTANEOUS MELANOMA; HAZARD RATIO; HUMAN; INTERMETHOD COMPARISON; LOCAL RECURRENCE FREE SURVIVAL; META ANALYSIS; OVERALL SURVIVAL; PATIENT SAFETY; PRACTICE GUIDELINE; PROBABILITY; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECURRENCE FREE SURVIVAL; REVIEW; SKIN SURGERY; SURGICAL TECHNIQUE; SYSTEMATIC ERROR; SYSTEMATIC REVIEW; TREATMENT OUTCOME; TUMOR VOLUME; BIOASSAY; DISEASE FREE SURVIVAL; EPIDEMIOLOGY; MELANOMA; METHODOLOGY; MINIMAL RESIDUAL DISEASE; PATHOLOGY; PREVENTION AND CONTROL; PROPORTIONAL HAZARDS MODEL; SKIN NEOPLASMS; STATISTICS AND NUMERICAL DATA; SURVIVAL RATE; TUMOR RECURRENCE;

BAYES THEOREM; DISEASE-FREE SURVIVAL; ENDPOINT DETERMINATION; HUMANS; MELANOMA; NEOPLASM RECURRENCE, LOCAL; NEOPLASM, RESIDUAL; PROPORTIONAL HAZARDS MODELS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RESEARCH DESIGN; SKIN NEOPLASMS; SURVIVAL RATE;

EID: 84955067567     PISSN: 03057372     EISSN: 15321967     Source Type: Journal    
DOI: 10.1016/j.ctrv.2015.10.013     Document Type: Review

References (40)

1. Garbe C., Eigentler T.K., Keilholz U., Hauschild A., Kirkwood J.M. Systematic review of medical treatment in melanoma: current status and future prospects. Oncologist 2011, 16(1):5-24.
2. Cascinelli N. Margin of resection in the management of primary melanoma. Semin Surg Oncol 1998, 14(4):272-275.
3. Cohn-Cedermark G., Rutqvist L.E., Andersson R., Breivald M., Ingvar C., Johansson H., et al. Long term results of a randomized study by the Swedish Melanoma Study Group on 2-cm versus 5-cm resection margins for patients with cutaneous melanoma with a tumor thickness of 0.8-2.0mm. Cancer 2000, 89(7):1495-1501.
4. Balch C.M., Soong S.J., Smith T., Ross M.I., Urist M.M., Karakousis C.P., et al. Long-term results of a prospective surgical trial comparing 2cm vs. 4cm excision margins for 740 patients with 1-4mm melanomas. Ann Surg Oncol 2001, 8(2):101-108.
5. Khayat D., Rixe O., Martin G., Soubrane C., Banzet M., Bazex J.A., et al. Surgical margins in cutaneous melanoma (2cm versus 5cm for lesions measuring less than 2.1-mm thick). Cancer 2003, 97(8):1941-1946.
6. Thomas J.M., Newton-Bishop J., A'Hern R., Coombes G., Timmons M., Evans J., et al. Excision margins in high-risk malignant melanoma. N Engl J Med 2004, 350(8):757-766.
7. Mocellin S., Pasquali S., Nitti D. The impact of surgery on survival of patients with cutaneous melanoma: revisiting the role of primary tumor excision margins. Ann Surg 2011, 253(2):238-243.
8. Sladden M.J., Balch C., Barzilai D.A., Berg D., Freiman A., Handiside T., et al. Surgical excision margins for primary cutaneous melanoma. Cochrane Database Syst Rev 2009, 4:CD004835. 10.1002/14651858.CD004835.pub2.
9. Lens M.B., Dawes M., Goodacre T., Bishop J.A. Excision margins in the treatment of primary cutaneous melanoma: a systematic review of randomized controlled trials comparing narrow vs wide excision. Arch Surg 2002, 137(10):1101-1105.
10. Marsden J.R., Newton-Bishop J.A., Burrows L., Cook M., Corrie P.G., Cox N.H., et al. Revised UK guidelines for the management of cutaneous melanoma 2010. J Plast Reconstr Aesthet Surg 2010, 63(9):1401-1419.
11. NCCN. Clinical practice guidelines in oncology (NCCN Guidelines), ; [accessed 27-10-15]. http://www.nccn.org/professionals/physician_gls/f_guidelines.asp#melanoma.
12. Cancer Council Australia and Australian Cancer Network SaNZGGW. Clinical Practice Guidelines for the Management of Melanoma in Australia and New Zealand, ; 2008 [accessed 26-10-15]. http://www.cancer.org.au/content/pdf/HealthProfessionals/ClinicalGuidelines/ClinicalPracticeGuidelines-ManagementofMelanoma.pdf.
13. Garbe C., Hauschild A., Volkenandt M., Schadendorf D., Stolz W., Reinhold U., et al. Evidence and interdisciplinary consensus-based German guidelines: surgical treatment and radiotherapy of melanoma. Melanoma Res 2008, 18(1):61-67.
14. Dummer R., Panizzon R., Bloch P.H., Burg G. Updated Swiss guidelines for the treatment and follow-up of cutaneous melanoma. Dermatology 2005, 210(1):39-44.
15. Dutch Working Group on Melanoma Skin melanoma 2006, Association of Comprehensive Cancer Centres (ACCC), Utrecht, The Netherlands.
16. Gillgren P., Drzewiecki K.T., Niin M., Gullestad H.P., Hellborg H., Mansson-Brahme E., et al. 2-cm versus 4-cm surgical excision margins for primary cutaneous melanoma thicker than 2 mm: a randomised, multicentre trial. Lancet 2011, 378(9803):1635-1642.
17. Hayes A.J., Maynard L., A'Hern R., Coombes G., Newton-Bishop J., Timmons M., et al. Long term follow up of survival in a randomised trial of wide or narrow excision margins in high risk primary melanoma. J Clin Oncol 2015, 33. (supple:abstr 9001) ASCO Abstract Number: 9001.
18. Moher D., Liberati A., Tetzlaff J., Altman D.G. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Int J Surg 2010, 8(5):336-341.
19. Cochrane Handbook for Systematic Reviews of Interventions 2008, John Wiley & Sons, Chichester. 1st ed.
20. Tierney J.F., Stewart L.A., Ghersi D., Burdett S., Sydes M.R. Practical methods for incorporating summary time-to-event data into meta-analysis. Trials 2007, 8:16.
21. Parmar M.K., Torri V., Stewart L. Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints. Stat Med 1998, 17(24):2815-2834.
22. Hughes M.D. Reporting Bayesian analyses of clinical trials. Stat Med 1993, 12(18):1651-1663.
23. Burton P.R. Helping doctors to draw appropriate inferences from the analysis of medical studies. Stat Med 1994, 13(17):1699-1713.
24. Karakousis C.P., Balch C.M., Urist M.M., Ross M.M., Smith T.J., Bartolucci A.A. Local recurrence in malignant melanoma: long-term results of the multiinstitutional randomized surgical trial. Ann Surg Oncol 1996, 3(5):446-452.
25. Moncrieff M, Henderson M. MelmarT melanoma margins trial investigating 1cm vs 2cm wide excision margins for primary cutaneous melanoma. Trial number: NCT02385214. Clinicaltrials.gov 2015; [accessed 26-10-15].
26. Altman D.G., Bland J.M. Absence of evidence is not evidence of absence. BMJ 1995, 311(7003):485.
27. Gardner M.J., Altman D.G. Confidence intervals rather than P values: estimation rather than hypothesis testing. Br Med J (Clin Res Ed) 1986, 292(6522):746-750.
28. Piaggio G., Elbourne D.R., Altman D.G., Pocock S.J., Evans S.J. Reporting of noninferiority and equivalence randomized trials: an extension of the CONSORT statement. JAMA 2006, 295(10):1152-1160.
29. Fueglistaler P., Adamina M., Guller U. Non-inferiority trials in surgical oncology. Ann Surg Oncol 2007, 14(5):1532-1539.
30. Slevin M.L., Stubbs L., Plant H.J., Wilson P., Gregory W.M., Armes P.J., et al. Attitudes to chemotherapy: comparing views of patients with cancer with those of doctors, nurses, and general public. BMJ 1990, 300(6737):1458-1460.
31. Newton-Bishop J.A., Nolan C., Turner F., McCabe M., Boxer C., Thomas J.M., et al. A quality-of-life study in high-risk (thickness>=or 2mm) cutaneous melanoma patients in a randomized trial of 1-cm versus 3-cm surgical excision margins. J Investig Dermatol Symp Proc 2004, 9(2):152-159.
32. Bergenmar M., Mansson-Brahme E., Hansson J., Brandberg Y. Surgical resection margins do not influence health related quality of life or emotional distress in patients with cutaneous melanoma: results of a prospective randomised trial. Scand J Plast Reconstr Surg Hand Surg 2010, 44(3):146-155.
33. McKinnon J.G., Starritt E.C., Scolyer R.A., McCarthy W.H., Thompson J.F. Histopathologic excision margin affects local recurrence rate: analysis of 2681 patients with melanomas
34. Pasquali S., Haydu L.E., Scolyer R.A., Winstanley J.B., Spillane A.J., Quinn M.J., et al. The importance of adequate primary tumor excision margins and sentinel node biopsy in achieving optimal locoregional control for patients with thick primary melanomas. Ann Surg 2013, 258(1):152-157.
35. Haydu L.E., Stollman J.T., Scolyer R.A., Spillane A.J., Quinn M.J., Saw R.P., et al. Minimum safe pathologic excision margins for primary cutaneous melanomas (1-2mm in thickness): analysis of 2131 patients treated at a single center. Ann Surg Oncol 2015, [Epub ahead of print].
36. Balch C.M., Gershenwald J.E., Soong S.J., Thompson J.F., Atkins M.B., Byrd D.R., et al. Final version of 2009 AJCC melanoma staging and classification. J Clin Oncol 2009, 27(36):6199-6206.
37. Veronesi U., Cascinelli N. Narrow excision (1-cm margin). A safe procedure for thin cutaneous melanoma. Arch Surg 1991, 126(4):438-441.
38. Veronesi U., Cascinelli N., Adamus J., Balch C., Bandiera D., Barchuk A., et al. Thin stage I primary cutaneous malignant melanoma. Comparison of excision with margins of 1 or 3cm. N Engl J Med 1988, 318(18):1159-1162.
39. Ringborg U., Andersson R., Eldh J., Glaumann B., Hafstrom L., Jacobsson S., et al. Resection margins of 2 versus 5cm for cutaneous malignant melanoma with a tumor thickness of 0.8 to 2.0 mm: randomized study by the Swedish Melanoma Study Group. Cancer 1996, 77(9):1809-1814.
40. Balch C.M., Urist M.M., Karakousis C.P., Smith T.J., Temple W.J., Drzewiecki K., et al. Efficacy of 2-cm surgical margins for intermediate-thickness melanomas (1 to 4mm). Results of a multi-institutional randomized surgical trial. Ann Surg 1993, 218(3):262-267.